Miller R E, Tran P B, Ishihara S, Syx D, Ren D, Miller R J, Valdes A M, Malfait A M
Division of Rheumatology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
Division of Rheumatology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
Osteoarthritis Cartilage. 2020 May;28(5):581-592. doi: 10.1016/j.joca.2020.01.008. Epub 2020 Jan 23.
Following destabilization of the medial meniscus (DMM), mice develop experimental osteoarthritis (OA) and associated pain behaviors that are dependent on the stage of disease. We aimed to describe changes in gene expression in knee-innervating dorsal root ganglia (DRG) after surgery, in order to identify molecular pathways associated with three pre-defined pain phenotypes: "post-surgical pain", "early-stage OA pain", and "persistent OA pain".
We performed DMM or sham surgery in 10-week old male C57BL/6 mice and harvested L3-L5 DRG 4, 8, and 16 weeks after surgery or from age-matched naïve mice (n = 3/group). RNA was extracted and an Affymetrix Mouse Transcriptome Array 1.0 was performed. Three pain phenotypes were defined: "post-surgical pain" (sham and DMM 4-week vs 14-week old naïve), "early OA pain" (DMM 4-week vs sham 4-week), and "persistent OA pain" (DMM 8- and 16-week vs naïve and sham 8- and 16-week). 'Top hit' genes were defined as P < 0.001. Pathway analysis (Ingenuity Pathway Analysis) was conducted using differentially expressed genes defined as P < 0.05. In addition, we performed qPCR for Ngf and immunohistochemistry for F4/80+ macrophages in the DRG.
For each phenotype, top hit genes identified a small number of differentially expressed genes, some of which have been previously associated with pain (7/67 for "post-surgical pain"; 2/14 for "early OA pain"; 8/37 for "persistent OA pain"). Overlap between groups was limited, with 8 genes differentially regulated (P < 0.05) in all three phenotypes. Pathway analysis showed that in the persistent OA pain phase many of the functions of differentially regulated genes are related to immune cell recruitment and activation. Genes previously linked to OA pain (CX3CL1, CCL2, TLR1, and NGF) were upregulated in this phenotype and contributed to activation of the neuroinflammation canonical pathway. In separate sets of mice, we confirmed that Ngf was elevated in the DRG 8 weeks after DMM (P = 0.03), and numbers of F4/80+ macrophages were increased 16 weeks after DMM (P = 0.002 vs Sham).
These transcriptomics findings support the idea that distinct molecular pathways discriminate early from persistent OA pain. Pathway analysis suggests neuroimmune interactions in the DRG contribute to initiation and maintenance of pain in OA.
在进行内侧半月板失稳(DMM)手术后,小鼠会患上实验性骨关节炎(OA)以及出现与疾病阶段相关的疼痛行为。我们旨在描述手术后支配膝关节的背根神经节(DRG)中基因表达的变化,以确定与三种预先定义的疼痛表型相关的分子途径:“术后疼痛”、“早期OA疼痛”和“持续性OA疼痛”。
我们对10周龄雄性C57BL/6小鼠进行DMM手术或假手术,并在术后4周、8周和16周或从年龄匹配的未手术小鼠(每组n = 3)中采集L3 - L5 DRG。提取RNA并进行Affymetrix小鼠转录组阵列1.0检测。定义了三种疼痛表型:“术后疼痛”(假手术组和DMM组术后4周与14周龄未手术小鼠相比)、“早期OA疼痛”(DMM组术后4周与假手术组术后4周相比)和“持续性OA疼痛”(DMM组术后8周和16周与未手术组及假手术组术后8周和16周相比)。“顶级命中”基因定义为P < 0.001。使用定义为P < 0.05的差异表达基因进行通路分析(Ingenuity通路分析)。此外,我们对DRG中的Ngf进行了qPCR检测,并对F4/80 +巨噬细胞进行了免疫组织化学检测。
对于每种表型,顶级命中基因鉴定出少量差异表达基因,其中一些基因先前已与疼痛相关(“术后疼痛”为7/67;“早期OA疼痛”为2/14;“持续性OA疼痛”为8/37)。组间重叠有限,在所有三种表型中有8个基因差异调节(P < 0.05)。通路分析表明,在持续性OA疼痛阶段,差异调节基因的许多功能与免疫细胞募集和激活有关。先前与OA疼痛相关的基因(CX3CL1、CCL2、TLR1和NGF)在该表型中上调,并促成神经炎症经典通路的激活。在另一组小鼠中,我们证实DMM术后8周DRG中Ngf升高(P = 0.03),DMM术后16周F4/80 +巨噬细胞数量增加(与假手术组相比,P = 0.002)。
这些转录组学研究结果支持这样一种观点,即不同的分子途径可区分早期和持续性OA疼痛。通路分析表明DRG中的神经免疫相互作用有助于OA疼痛的起始和维持。